These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10792435)

  • 1. MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes.
    Fernandez-Gonzalez A; Pérez-Otaño I; Morgan JI
    Eur J Neurosci; 2000 May; 12(5):1573-83. PubMed ID: 10792435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
    Xu X; Song N; Wang R; Jiang H; Xie J
    Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes.
    Schmidt J; Mertz K; Morgan JI
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):50-9. PubMed ID: 10581397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
    J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term induction of haem oxygenase-1 (HSP-32) in astrocytes and microglia following transient focal brain ischaemia in the rat.
    Koistinaho J; Miettinen S; Keinänen R; Vartiainen N; Roivainen R; Laitinen JT
    Eur J Neurosci; 1996 Nov; 8(11):2265-72. PubMed ID: 8950091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1.
    Innamorato NG; Jazwa A; Rojo AI; García C; Fernández-Ruiz J; Grochot-Przeczek A; Stachurska A; Jozkowicz A; Dulak J; Cuadrado A
    PLoS One; 2010 Jul; 5(7):e11838. PubMed ID: 20676377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mouse MPTP model: gene expression changes in dopaminergic neurons.
    Kühn K; Wellen J; Link N; Maskri L; Lübbert H; Stichel CC
    Eur J Neurosci; 2003 Jan; 17(1):1-12. PubMed ID: 12534964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R; Smeyne RJ; Morgan JI
    Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J; Graham DG; Montine TJ; Ho YS
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired CBS-H
    Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
    Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H; Underwood R; Lavalley N; Yacoubian TA
    Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute phencyclidine neurotoxicity in rat forebrain: induction of haem oxygenase-1 and attenuation by the antioxidant dimethylthiourea.
    Rajdev S; Fix AS; Sharp FR
    Eur J Neurosci; 1998 Dec; 10(12):3840-52. PubMed ID: 9875361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
    Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
    Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
    Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.